# ðŸ¦… Federal Law Reference Directory

> ðŸ“Œ Laws containing the "fun fact" emoji (ðŸ¤¯) in their `headers` are not ones you have to remember by name.

---

**FDC, FDCA, & Amendments** (ðŸ”— [Link](./fdc_fdca.md))

| **Title** | **Notes** |
|-----------|-----------|
| **Pure Food, Drugs, & Cosmetics Act (1906)** | Prohibited adulterated or misbranded drugs in interstate commerce. Required purity standards, labeling of dangerous ingredients, and initiated FDA enforcement. |
| **Food, Drug, and Cosmetic Act (FDCA, 1938)** | Required premarket safety approval of drugs after sulfanilamide deaths. Expanded FDA authority to cosmetics and devices. Required labeling with warnings and directions. |
| **Durham-Humphrey Amendment (1951)** | Distinguished Rx and OTC drugs. Authorized verbal prescriptions and refills. Required "Rx Only" legend on prescription drugs. |
| **Kefauver-Harris Amendment (1962)** | Required drug effectiveness proof and FDA pre-approval. Instituted GMP standards and adverse event reporting after thalidomide tragedy. |
| **Medical Device Amendments (1976)** | Classified devices by risk (Class Iâ€“III). Required premarket approval for high-risk (Class III) devices after the Dalkon Shield disaster. |
| **Orphan Drug Act (1983)** | Provided incentives (tax credits, market exclusivity, grants) for developing drugs for rare diseases. |
| **Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman, 1984)** | Created ANDA pathway for generics. Allowed brand drugmakers to recover patent life lost during FDA approval. Balanced generic entry with brand protection. |
| **Prescription Drug Marketing Act (PDMA, 1987)** | Prohibited drug reimportation (except by manufacturer), regulated drug sample distribution, and required wholesale distributor licensure. |
| **Food & Drug Administration Amendments Act (FDAAA, 2007)** | Required clinical trial registration and pediatric study requirements. Authorized FDA to mandate REMS programs for certain high-risk drugs (e.g., opioids, biologics). |
| **Drug Quality and Security Act (DQSA, 2013)** | Enhanced oversight of compounded drugs and drug supply chain security. Created "outsourcing facility" category subject to cGMP and FDA inspections. |

---

**Extended Packaging & Labeling Policy** (ðŸ”— [Link](./fdc_fdca.md))

| **Title** | **Notes** |
|-----------|-----------|
| **Fair Packaging & Labeling Act (FPLA, 1967)** | Requires clear, truthful labels showing manufacturer info, quantity, and product identity. |
| **Drug Listing Act (1972)** | Requires drugs to have an 11-digit National Drug Code identifying manufacturer, product, and packaging. |
| **Drug Supply Chain Security Act (DSCSA, 2013)** | Mandates unique product identifiers, 2D barcodes, electronic tracking, and rapid counterfeit reporting. |

---

**HIPAA & Amendments** (ðŸ”— [Link](./hipaa.md))

| **Title** | **Notes** |
|-----------|-----------|
| **HIPAA (1996)** | Protects patient privacy by regulating the use, disclosure, and safeguarding of PHI by Covered Entities. |
| **HITECH Act (2009)** | Expands HIPAA to include business associates and promotes secure use of electronic health records. |

---

Todo:

- consolidate healthcare coverage
- consolidate csa_cmea
